The legacy of Viagra and its impact on the pharmaceutical sector presents a complex question regarding its continued appeal as an investment. Initially a remarkable success, generating vast revenues, generic competition has considerably eroded financial returns. While established pharmaceutical firms continue patents on related therapies and explor

The performance of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced substantial volatility. Investors are now facing the consequences of rival medic